(Limited) Credelio Chewable

When it comes to caring for your four-legged friend, effective, reliable protection is key. Credelio® (lotilaner) is an oral tick and flea medication that delivers powerful protection in a small, beef-flavoured tablet that is easy enough to treat all puppies and dogs 8 weeks of age or older that weigh 2kg or greater.

Sizes:

• Medium (11-22kg): 3 x 450mg tablets

Click Here for Package Insert.

More Info

Composition:

• Credelio 450 mg Chewable Tablets contain: Lotilaner 450 mg

Credelio starts killing fleas in 4 hours and kills 99% within 8 hours for 35 days. Credelio is greater than 97% effective against labelled tick species 48 hours after administration or infestation for 30 days. In a controlled European study, Credelio starts killing ticks (I. Ricinus) in 4 hours.

Credelio's active ingredient, lotilaner, is a member of the isoxazoline family, a novel class of parasiticides that target nerve receptors of ticks and fleas for powerful protection.

Indications:

Credelio kills adult fleas and is indicated for the treatment and prevention of flea infestations and treatment and control of tick infestations (lone star tick, American dog tick, black-legged tick, and brown dog tick) for one month in dogs and puppies 8 weeks and older and 2kg or greater.

Directions for use:

• Credelio is given orally, once a month, and must be administered with food or given within 30 minutes of feeding.
• Consult your veterinarian for the appropriate tablet dose for your dog.
• Treatment can begin any time of the year and can continue year-round without interruption.
• If you miss a dose, administer a tablet immediately. Resume monthly dosing beginning one month from the last tablet consumed.

Credelio comes in convenient 1-dose packs. Credelio is not for use in humans. Like all tick-and flea-control products, keep Credelio out of the reach of children.

Dosage:

Important Safety Information:

Lotilaner is a member of the isoxazoline class of drugs. This class has been associated with neurologic adverse reactions including tremors, incoordination, and seizures. Seizures have been reported in dogs receiving this class of drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. The safe use of Credelio in breeding, pregnant or lactating dogs has not been evaluated. The most frequently reported adverse reactions are weight loss, elevated blood urea nitrogen, increased urination, and diarrhoea. For complete safety information, please see Credelio product label or ask your veterinarian.

Reviews